INTEGRA Biosciences and Viaflo Corporation Join Forces
News Aug 18, 2009
The combining of the two companies provides for strong mutual benefits. INTEGRA Biosciences will be receiving direct access to the important US Market through the Viaflo sales network. INTEGRA Biosciences also receives access to a complete line of new and innovative handheld pipetting systems and associated plastic disposables. Viaflo will receive strong representation and access to European and global markets through INTEGRA Biosciences and their large network of specialist distributors. In the USA - Viaflo will also benefit from selling the complimentary, well recognised, and established INTEGRA Biosciences product portfolio. The INTEGRA Biosciences and Viaflo products complement each other perfectly.
The new group, in the last 2 years has translated customer needs into the introduction of many new innovative and reliable products. With specialists in sales, marketing, research, development and manufacturing it maintains close relations and collaborations with customers worldwide for the purpose of providing cutting edge technologies to the health care industry.
As a result of constant growth achieved over recent years, INTEGRA Biosciences has announced that it will also move from its current location into a larger new modern industrial building in Zizers, Switzerland.
Methane Hydrate Formation Studied Using Novel MicroreactorNews
Researchers at the NYU Tandon School of Engineering are using a novel means of studying how methane and water form methane hydrate that allows them to examine discrete steps in the process faster and more efficiently.READ MORE
University of Huddersfield Honorary Award Goes to RSC’s First Woman PresidentNews
The first woman President of the Royal Society of Chemistry, Professor Lesley Yellowlees, will collect an honorary award from University of Huddersfield, which will be presented at the University’s November Award Ceremonies.READ MORE
Drug Discovery Alliance Formed to Help Increase Drug Development Success RateNews
Two prominent preclinical safety companies have launched a unique European alliance to address the high safety-related failure rate in drug development.READ MORE